Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-22-000677
Filing Date
2022-05-10
Accepted
2022-05-10 14:56:53
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tlcc-20220331.htm   iXBRL 10-Q 1215922
7 EXHIBIT 31.1 ex311_1.htm EX-31.1 11898
8 EXHIBIT 31.2 ex312_2.htm EX-31.2 11880
9 EXHIBIT 32.1 ex321_3.htm EX-32.1 5347
10 EXHIBIT 32.2 ex322_4.htm EX-32.2 4771
  Complete submission text file 0001753926-22-000677.txt   6141516

Data Files

Seq Description Document Type Size
2 DEFINITION tlcc-20220331_def.xml EX-101.DEF 202205
3 PRESENTATION tlcc-20220331_pre.xml EX-101.PRE 330688
4 CALCULATION tlcc-20220331_cal.xml EX-101.CAL 67071
5 LABEL tlcc-20220331_lab.xml EX-101.LAB 545205
6 SCHEMA tlcc-20220331.xsd EX-101.SCH 42760
53 EXTRACTED XBRL INSTANCE DOCUMENT tlcc-20220331_htm.xml XML 1042985
Mailing Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431
Business Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431 561-443-5001
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

EIN.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 22908995
SIC: 2833 Medicinal Chemicals & Botanical Products